WEST PHARMACEUTICAL SERVICES, INC. (WST) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
56/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinWST / S&P 43.34% / 15.20% |
LoseWST / S&P 12.38% / 15.00% |
LoseWST / S&P 16.92% / 50.40% |
| 2026-Q10/3 |
LoseWST / S&P -8.82% / -4.33% |
LoseWST / S&P 11.23% / 11.30% |
LoseWST / S&P 17.43% / 27.70% |
| 2025-Q41/3 |
WinWST / S&P 4.97% / 2.65% |
LoseWST / S&P 6.25% / 9.00% |
LoseWST / S&P 1.49% / 13.40% |
| 2025-Q32/3 |
WinWST / S&P 19.99% / 8.12% |
WinWST / S&P 4.92% / 4.61% |
LoseWST / S&P 0.15% / 13.45% |
| 2025-Q20/3 |
LoseWST / S&P -2.17% / 10.94% |
LoseWST / S&P 2.90% / 4.83% |
LoseWST / S&P -4.98% / 10.63% |
| 2025-Q10/3 |
LoseWST / S&P -31.61% / -4.27% |
LoseWST / S&P -1.12% / 4.98% |
LoseWST / S&P -15.96% / 10.57% |
| 2024-Q41/3 |
WinWST / S&P 9.20% / 2.41% |
LoseWST / S&P -1.92% / 5.25% |
LoseWST / S&P -15.10% / 6.15% |
| 2024-Q30/3 |
LoseWST / S&P -8.81% / 5.89% |
LoseWST / S&P -1.71% / 5.89% |
LoseWST / S&P -9.16% / 6.11% |
| 2024-Q20/3 |
LoseWST / S&P -16.72% / 4.28% |
LoseWST / S&P 0.38% / 5.38% |
LoseWST / S&P 2.33% / 5.12% |
| 2024-Q11/3 |
WinWST / S&P 12.44% / 10.56% |
LoseWST / S&P 1.56% / 5.71% |
LoseWST / S&P 3.98% / 5.59% |
| 2023-Q40/3 |
LoseWST / S&P -6.10% / 11.69% |
LoseWST / S&P 2.18% / 6.81% |
LoseWST / S&P 1.94% / 7.78% |
| 2023-Q31/3 |
WinWST / S&P -1.85% / -3.27% |
LoseWST / S&P 0.60% / 7.52% |
LoseWST / S&P -10.06% / -5.03% |
| 2023-Q21/3 |
WinWST / S&P 10.45% / 8.74% |
LoseWST / S&P -2.14% / 9.50% |
LoseWST / S&P -23.41% / -8.57% |
| 2023-Q11/3 |
WinWST / S&P 47.32% / 7.50% |
LoseWST / S&P 0.09% / 10.77% |
LoseWST / S&P -18.64% / -15.69% |
| 2022-Q41/3 |
LoseWST / S&P -4.28% / 7.56% |
LoseWST / S&P 1.95% / 11.88% |
WinWST / S&P -10.74% / -17.99% |
| 2022-Q31/3 |
LoseWST / S&P -18.57% / -4.88% |
LoseWST / S&P 8.50% / 13.47% |
WinWST / S&P 2.36% / -1.41% |
| 2022-Q22/3 |
LoseWST / S&P -26.34% / -16.10% |
WinWST / S&P 16.10% / 13.71% |
WinWST / S&P 31.14% / 11.04% |
| 2022-Q12/3 |
LoseWST / S&P -12.39% / -4.60% |
WinWST / S&P 23.85% / 15.97% |
WinWST / S&P 60.57% / 42.23% |
| 2021-Q41/3 |
LoseWST / S&P 10.52% / 11.03% |
WinWST / S&P 31.89% / 15.00% |
LoseWST / S&P 89.08% / 96.40% |
| 2021-Q33/3 |
WinWST / S&P 18.28% / 0.58% |
WinWST / S&P 31.60% / 10.77% |
WinWST / S&P 94.69% / 69.42% |
| 2021-Q23/3 |
WinWST / S&P 27.51% / 8.55% |
WinWST / S&P 29.66% / 6.58% |
WinWST / S&P 80.00% / 51.81% |
| 2021-Q12/3 |
LoseWST / S&P -0.48% / 6.17% |
WinWST / S&P 23.21% / -1.06% |
WinWST / S&P 60.81% / 7.39% |
| 2020-Q42/3 |
LoseWST / S&P 3.12% / 12.15% |
WinWST / S&P 16.69% / -3.72% |
WinWST / S&P 42.68% / -33.42% |
| 2020-Q33/3 |
WinWST / S&P 21.08% / 8.93% |
WinWST / S&P 13.70% / -2.04% |
WinWST / S&P 35.74% / -27.10% |
| 2020-Q23/3 |
WinWST / S&P 49.35% / 20.54% |
WinWST / S&P 10.07% / -0.46% |
WinWST / S&P 25.41% / -27.11% |
| 2020-Q13/3 |
WinWST / S&P 1.38% / -19.60% |
WinWST / S&P 8.18% / 3.47% |
WinWST / S&P 19.66% / -14.75% |
| 2019-Q42/3 |
LoseWST / S&P 6.12% / 9.07% |
WinWST / S&P 7.13% / 5.36% |
WinWST / S&P 16.73% / 2.99% |
| 2019-Q32/3 |
WinWST / S&P 13.46% / 1.70% |
LoseWST / S&P 4.75% / 5.02% |
WinWST / S&P 48.06% / 0.21% |
| 2019-Q22/3 |
WinWST / S&P 13.71% / 4.30% |
LoseWST / S&P 5.39% / 6.64% |
WinWST / S&P 51.50% / 8.65% |
| 2019-Q11/3 |
LoseWST / S&P 12.58% / 13.65% |
LoseWST / S&P 7.26% / 8.12% |
WinWST / S&P 64.77% / 14.29% |
| 2018-Q41/3 |
LoseWST / S&P -20.50% / -13.52% |
LoseWST / S&P 7.40% / 9.05% |
WinWST / S&P 38.19% / 18.23% |
| 2018-Q31/3 |
WinWST / S&P 24.53% / 7.71% |
LoseWST / S&P 9.24% / 10.21% |
LoseWST / S&P -17.60% / 19.06% |
| 2018-Q21/3 |
WinWST / S&P 12.64% / 3.43% |
LoseWST / S&P 8.59% / 9.03% |
LoseWST / S&P -14.16% / 14.46% |
| 2018-Q10/3 |
LoseWST / S&P -10.39% / -0.76% |
LoseWST / S&P 6.02% / 7.68% |
LoseWST / S&P -27.27% / 12.46% |
| 2017-Q40/3 |
LoseWST / S&P 2.65% / 6.64% |
LoseWST / S&P 5.96% / 7.03% |
LoseWST / S&P 4.19% / 13.82% |
| 2017-Q31/3 |
LoseWST / S&P 1.98% / 4.48% |
LoseWST / S&P 5.33% / 5.68% |
WinWST / S&P 35.14% / 17.57% |
| 2017-Q23/3 |
WinWST / S&P 16.01% / 3.09% |
WinWST / S&P 6.19% / 4.83% |
WinWST / S&P 70.07% / 17.74% |
| 2017-Q12/3 |
LoseWST / S&P -3.65% / 6.07% |
WinWST / S&P 7.62% / 3.67% |
WinWST / S&P 110.43% / 13.32% |
| 2016-Q43/3 |
WinWST / S&P 14.07% / 3.82% |
WinWST / S&P 7.81% / 2.09% |
WinWST / S&P 46.92% / 7.05% |
| 2016-Q32/3 |
LoseWST / S&P -1.67% / 3.85% |
WinWST / S&P 6.95% / 0.20% |
WinWST / S&P 44.53% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | WST total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 40.58% | 20.78% |
| Annualized return | 40.58% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | WST total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -22.61% | 83.14% |
| Annualized return | -5.00% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | WST total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 339.17% | 319.30% |
| Annualized return | 15.95% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |